Invention Grant
- Patent Title: Anti-factor IX Padua antibodies
-
Application No.: US16301962Application Date: 2017-05-16
-
Publication No.: US11098132B2Publication Date: 2021-08-24
- Inventor: Dirk Voelkel , Robert Pachlinger , Hanspeter Rottensteiner , Alfred Weber , Andrea Engelmaier
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Troutman Pepper Hamilton Sanders LLP
- International Application: PCT/US2017/032808 WO 20170516
- International Announcement: WO2017/200981 WO 20171123
- Main IPC: C07K16/36
- IPC: C07K16/36 ; G01N33/573 ; C07K16/00 ; G01N33/86
Abstract:
Provided herein are anti-Factor IX Padua binding constructs, e.g., antibodies and antigen-binding fragments thereof. Related polypeptides, conjugates and kits are also provided. The inventions may be used in methods of detecting Factor IX Padua in a sample.
Public/Granted literature
- US20190194351A1 ANTI-FACTOR IX PADUA ANTIBODIES Public/Granted day:2019-06-27
Information query
